Integra Lifesciences Holdings Corp
(STU:IL3)
€
23.8
0.8 (3.48%)
Market Cap: 1.83 Bil
Enterprise Value: 3.43 Bil
PE Ratio: 0
PB Ratio: 1.29
GF Score: 71/100 
Integra Lifesciences Holdings Corp at Wells Fargo Healthcare Conference Transcript
Sep 05, 2019 / 05:55PM GMT
Release Date Price:
€53.11
(+0.45%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst
Good afternoon. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. And it's my pleasure to host this session with the management team from Integra LifeSciences. With us, we have Glenn Coleman, the Chief Operating Officer; Carrie Anderson, the new CFO; and Mike Beaulieu, our Investor Relations. Glenn and Carrie, thank you very much for coming.
Carrie Anderson
Integra LifeSciences Holdings Corporation - Corporate VP, CFO & Principal Financial Officer
You're welcome.
Glenn G. Coleman
Integra LifeSciences Holdings Corporation - COO & Corporate VP of International
Thanks for having us.
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Analyst
The format is going to be a fireside chat. If anybody in the audience has a question, please raise your hand.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers